Violating competition laws never pays
Competition laws – also referred to as antitrust laws – are designed to protect competition. They prohibit business behaviour which has the objective or the effect of preventing, restricting or distorting competition (e.g. price fixing and the allocation of markets or customers).
Roche supports all efforts to promote and protect competition, including the legitimate protection of intellectual property and marketing rights.
Roche has set up a comprehensive antitrust compliance program. Employees who have to deal with competition issues in their work are expected to understand the basic principles of competition law and the importance of complying with such laws. If an answer to a specific antitrust question is not clear, employees must seek help and advice.
The penalties for breaching competition laws are severe. In addition to Roche’s liability as a company, employees who engage in anticompetitive behaviour will be subject to penalties.
Despite Roche’s commitment to complying with applicable competition laws, Roche may become the subject of an unannounced investigation by antitrust authorities (called a “dawn raid”). In the event of an investigation, Roche will fully cooperate with the investigators and will not destroy any documents, data or official seals.
Roche employees involved in a tender process must be aware of and comply with the applicable tender law regulations. Transparency must be maintained throughout the procurement cycle by adhering to applicable formal procedures and provide the governmental decision makers with correct, transparent and non-discriminatory data.
Roche respects the legitimate undertakings of its competitors, including generic and biosimilar manufacturers. However, it is expected that they comply with applicable laws, regulations and industry codes. Roche does not tolerate misleading claims which disparage its products, and protects its products and interests against unfair competition.